Asia Pacific Biomaterials Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Biomaterials are the substance which is used in medical procedures such as tissues replacement or a diagnostic and to repair damaged organs. Biomaterials either may be artificial or natural materials which will relate biological systems for cardiovascular, orthopaedic, and neurological disorders. These have some applications in the biomineralisation, biomolecules, biotechnology, and Biomed engineering.

Asia Pacific Biomaterials Market Segments Size & Growth:

Asia Pacific Biomaterials Market is accounted for $14.5 billion in 2017 and expected to grow at a CAGR of 17% to reach $32.2 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth are by the superior properties of biomaterial, increase in inventions in biomaterials, rise in ageing population, high per capita income. However, safety issues and compatibility hinder the growth of the biomaterials market.

Asia Pacific Biomaterials Market Segments Share:

Asia Pacific Biomaterials Market is categorised into by speciality which consists of cardiology, neurology, orthopaedics, dental, and gynaecology. Cardiology and orthopaedics have the most significant share due to increase in cardiovascular diseases and demand for orthopaedic surgeries. By the type of materials, biomaterials market is classified by bioactive material, bioinert material, and a bioresorbable material. Bioinert material has the highest market because of demand for orthopaedic procedures to support bones and their replacements.

By Geography, China is dominating the biomaterials market, and the growth in the Asia Pacific is mainly attributed to rising demand for cardiovascular diseases and orthopaedic surgeries. Furthermore, India is witnessing the fastest growth during the forecast period, due to the rise in funds offering for biomaterials.

Asia Pacific Biomaterials Market Segments Trends:

• Corbion N.V. has developed a bioplastic material PLA (polylactic acid) made from sugarcane and sugar beets which helps in decreasing carbon footprints.
• In February 2017, Dentsply Tulsa and Dentsply Maillefer have been combined to form a unit know as Dentsply Sirona Endodontics to develop better root treatments with less number of steps.
• In August 2017, DuPont has acquired Granular Inc. provider of software and analytics equipment which helps farms.

Asia Pacific Biomaterials Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

• LG Life Sciences Limited
• Teva Pharmaceuticals
• Celltrion
• Hospira
• Accord Healthcare